Pulmatrix, Inc.
PULM
$1.54
$0.031.99%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/13/2026
-
Seeking Alpha - Healthcare
8/13/2026
-
PR Newswire
7/26/2026
-
The Cerbat Gem
7/10/2026
-
Globe Newswire
7/10/2026
-
PR Newswire
5/16/2026
-
The Cerbat Gem
5/16/2026
-
The Cerbat Gem
5/15/2026
-
GuruFocus
5/15/2026
-
PR Newswire
4/21/2026
-
TipRanks Financial Blog
4/21/2026
-
PR Newswire
4/13/2026
-
Business Wire
3/27/2026
-
TipRanks Financial Blog
3/27/2026
-
TipRanks Financial Blog
3/26/2026
-
Nasdaq News: Markets
3/26/2026
-
The Fly
3/26/2026
-
PR Newswire
3/26/2026
-
FierceBiotech.com - Biotech
3/2/2026
-
Stocktwits News Feed
3/2/2026
-
TipRanks Financial Blog
3/2/2026
-
The Fly
3/2/2026
-
PR Newswire
3/2/2026
-
FierceBiotech.com - Biotech
2/26/2026
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 15, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888 355 4440
Address
945 Concord Street
Suite 1217
Framingham, MA 01701
Suite 1217
Framingham, MA 01701
Country
Year Founded
Business Description
Sector
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the...
more